| Pepper Money Limited (PPM) ORDINARY FULLY PAID |
Financials |
$759 |
Application for quotation of securities - PPM
|
24 Oct 2024 8:52AM |
$1.450 |
$1.710 |
risen by
17.93%
|
|
| Aurelia Metals Limited (AMI) ORDINARY FULLY PAID |
Materials |
$347 |
2024 Notice of Annual General Meeting/Proxy Form
|
24 Oct 2024 8:51AM |
$0.190 |
$0.205 |
risen by
7.89%
|
|
| Adairs Limited (ADH) ORDINARY FULLY PAID |
Consumer Discretionary |
$456 |
Trading Update
|
24 Oct 2024 8:51AM |
$2.320 |
$2.580 |
risen by
11.21%
|
|
ADH - Price-sensitive ASX Announcement
Full Release
Key Points
- Group sales up 4.8% compared to FY24.
- Adairs brand sales increased by 8.6% for FY25.
- Strong sales growth of 16.1% in the last eight weeks.
- Successful deployment of new Warehouse Management System at National Distribution Centre.
- Continued growth for Mocka with sales up 19.7% in Australia.
- Optimistic outlook for FY25 with focus on gross margin management and operational efficiencies.
- Revised down expectations for new Focus on Furniture stores to two.
- Capital expenditure expected to be around $13m to $15m.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Astron Corporation Limited (ATR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$97 |
Letter to Ineligible Shareholders
|
24 Oct 2024 8:50AM |
$0.655 |
$0.465 |
fallen by
29.01%
|
|
| Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID |
Health Care |
$845 |
CAJ: Notice of Second Court Hearing
|
24 Oct 2024 8:50AM |
$3.110 |
$2.270 |
fallen by
27.01%
|
|
| Capitol Health Limited (CAJ) ORDINARY FULLY PAID |
Health Care |
- |
Notice of Second Court Hearing
|
24 Oct 2024 8:50AM |
$0.380 |
$0.385 |
risen by
1.32%
|
|
| Chorus Limited (CNU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Communication Services |
$3,449 |
Chorus annual shareholders meeting
|
24 Oct 2024 8:49AM |
$8.090 |
$7.950 |
fallen by
1.73%
|
|
| Astron Corporation Limited (ATR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$97 |
Entitlement Offer Booklet
|
24 Oct 2024 8:48AM |
$0.655 |
$0.465 |
fallen by
29.01%
|
|
ATR - Price-sensitive ASX Announcement
Full Release
Key Points
- The offer price is $0.66 per New CDI, representing a 12.0% discount to the last traded price before the announcement.
- The Entitlement Offer is non-renounceable and entitlements will not be tradeable.
- The record date for the entitlement offer is 22 October 2024.
- The Entitlement Offer is expected to close on 19 November 2024.
- Funds raised will be used for preparations for commercial production at the Donald Project.
- All directors have indicated intentions to take up their full rights under the Entitlement Offer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ryder Capital Limited (RYD) ORDINARY FULLY PAID |
Financials |
$105 |
Update - Notification of buy-back - RYD
|
24 Oct 2024 8:47AM |
$1.320 |
$1.290 |
fallen by
2.27%
|
|
| EZZ Life Science Holdings Limited (EZZ) ORDINARY FULLY PAID |
Health Care |
$125 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
24 Oct 2024 8:47AM |
$3.550 |
$2.650 |
fallen by
25.35%
|
|
EZZ - Price-sensitive ASX Announcement
Full Release
Key Points
- EZZ achieved receipts from customers of $15.4 million, a 128.4% increase year-on-year.
- The company launched four new functional food products targeting children and adults.
- EZZ signed a three-year sponsorship deal with the Australian Open to increase brand outreach in Asia.
- The company hosted various promotional events in Sydney to boost brand awareness.
- EZZ moved to a new multi-purpose headquarters in Lidcombe, NSW.
- The cash balance at the end of the quarter stood at $18.2 million with no debt.
- EZZ plans to expand its market presence in the United States following FDA product approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lakes Blue Energy NL (LKO) ORDINARY FULLY PAID |
Energy |
$0 |
Initial Director's Interest Notice
|
24 Oct 2024 8:47AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| Astron Corporation Limited (ATR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$97 |
Opening of Entitlement Offer
|
24 Oct 2024 8:47AM |
$0.655 |
$0.465 |
fallen by
29.01%
|
|
ATR - Price-sensitive ASX Announcement
Full Release
Key Points
- Entitlement Offer opened on 24 October 2024.
- Aims to raise approximately $10 million.
- Eligible securityholders can subscribe for 1 new CDI for every 12 held.
- Offer price set at $0.66 per new CDI.
- Closing date for the offer is 19 November 2024.
- The offer is not underwritten.
- Key directors have indicated they will fully participate.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ikeGPS Group Limited (IKE) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$135 |
IKE 1H FY25 Performance Update
|
24 Oct 2024 8:45AM |
$0.560 |
$0.840 |
risen by
50%
|
|
IKE - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant growth in underlying subscription revenue.
- Three-year subscription revenue CAGR of +38%.
- Expected increase in FY25 subscription revenue by ~40% or greater vs pcp.
- +34% YoY growth in the exit run rate of annual platform subscription revenue.
- Exit Run Rate of annual platform subscription has grown to NZ$13.2m as at 30 September 2024.
- Subscription seat license growth of +179% over the past year.
- Three-year transaction revenue CAGR of +20%.
- Total cash and receivables as at 30 September 2024 of ~NZ$11.1m.
- Investment into product development is paying back with IKE PoleForeman.
- IKE expects further major customers to close in the near term.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AnteoTech Limited (ADO) ORDINARY FULLY PAID |
Materials |
$30 |
Notice of Annual General Meeting/Proxy Form
|
24 Oct 2024 8:44AM |
$0.026 |
$0.011 |
fallen by
57.69%
|
|
| Aurizon Holdings Limited (AZJ) ORDINARY FULLY PAID |
Industrials |
$5,426 |
Update - Notification of buy-back - AZJ
|
24 Oct 2024 8:44AM |
$3.470 |
$3.060 |
fallen by
11.82%
|
|
| Pepper Money Limited (PPM) ORDINARY FULLY PAID |
Financials |
$759 |
Application for quotation of securities - PPM
|
24 Oct 2024 8:42AM |
$1.450 |
$1.710 |
risen by
17.93%
|
|
| Dubber Corporation Limited (DUB) ORDINARY FULLY PAID |
Information Technology |
$50 |
FY24 AGM Access Letter, Notice of Meeting and Proxy
|
24 Oct 2024 8:42AM |
$0.019 |
$0.019 |
fallen by
0%
|
|
| Oncosil Medical Limited (OSL) ORDINARY FULLY PAID |
Health Care |
$14 |
Trading Halt
|
24 Oct 2024 8:42AM |
$0.013 |
$1.005 |
risen by
7,630.77%
|
|
OSL - Price-sensitive ASX Announcement
Full Release
Key Points
- OncoSil Medical Ltd has requested a trading halt.
- The halt is pending an announcement regarding a capital raise.
- The trading halt will last until 28 October 2024 or until the announcement is released.
- The company is not aware of any reason for the trading halt request to be denied.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vinyl Group Ltd (VNL) ORDINARY FULLY PAID |
Information Technology |
$141 |
Notice of Annual General Meeting
|
24 Oct 2024 8:41AM |
$0.115 |
$0.105 |
fallen by
8.70%
|
|
| Paradigm Biopharmaceuticals Limited (PAR) ORDINARY FULLY PAID |
Health Care |
$117 |
Proposed issue of securities - PAR
|
24 Oct 2024 8:41AM |
$0.205 |
$0.300 |
risen by
46.34%
|
|
| Regis Healthcare Limited (REG) ORDINARY FULLY PAID |
Health Care |
$2,326 |
Notice of Annual General Meeting/Proxy Form
|
24 Oct 2024 8:40AM |
$6.630 |
$7.720 |
risen by
16.44%
|
|
| Vinyl Group Ltd (VNL) ORDINARY FULLY PAID |
Information Technology |
$141 |
Notice of Annual General Meeting/Proxy Form
|
24 Oct 2024 8:40AM |
$0.115 |
$0.105 |
fallen by
8.70%
|
|
| Visioneering Technologies Inc (VTI) ORDINARY FULLY PAID |
Health Care |
- |
Investor Presentation
|
24 Oct 2024 8:38AM |
$0.115 |
$0.066 |
fallen by
42.61%
|
|
VTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Pediatric myopia presents a total addressable market of over 500 million children and young adults.
- The market for myopia treatment is expected to grow from approximately $2 billion to over $17 billion.
- NaturalVue Multifocal contact lenses show a significant reduction in myopia progression based on clinical studies.
- VTI's net revenue for Q3 FY '24 was $2,282,000, marking a 10% increase from the previous year.
- Gross margin improved to 58.4% compared to 57.0% in Q3 FY '23.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| iTech Minerals Ltd (ITM) ORDINARY FULLY PAID |
Materials |
$6 |
Gold-Silver-Antimony Prospectivity Expanded - Reynolds Range
|
24 Oct 2024 8:38AM |
$0.068 |
$0.033 |
fallen by
51.47%
|
|
ITM - Price-sensitive ASX Announcement
Full Release
Key Points
- iTech Minerals Ltd focuses on gold-silver-antimony exploration at Reynolds Range.
- High-grade mineralization identified at Sabre, Falchion, and Lander 1 prospects.
- Expansion of mineralization occurs within the Lander Rock Formation.
- The mineralization is part of a broader soil anomaly covering 6.3km by 2.5km.
- Preparation for drilling at Scimitar Copper-Gold Prospect is ongoing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arovella Therapeutics Limited (ALA) ORDINARY FULLY PAID |
Health Care |
$114 |
Notice Under Section 708A
|
24 Oct 2024 8:37AM |
$0.180 |
$0.096 |
fallen by
46.67%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
